ABN Amro Investment Solutions Invests $916,000 in STERIS plc $STE

ABN Amro Investment Solutions purchased a new position in shares of STERIS plc (NYSE:STE) during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 4,143 shares of the medical equipment provider’s stock, valued at approximately $916,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Trust Co. of Vermont raised its position in STERIS by 30.2% in the 4th quarter. Trust Co. of Vermont now owns 164 shares of the medical equipment provider’s stock valued at $42,000 after purchasing an additional 38 shares during the last quarter. Bailard Inc. raised its holdings in shares of STERIS by 3.5% in the fourth quarter. Bailard Inc. now owns 1,118 shares of the medical equipment provider’s stock valued at $283,000 after buying an additional 38 shares during the last quarter. Geneos Wealth Management Inc. raised its holdings in shares of STERIS by 34.9% in the second quarter. Geneos Wealth Management Inc. now owns 174 shares of the medical equipment provider’s stock valued at $42,000 after buying an additional 45 shares during the last quarter. Ascent Group LLC lifted its position in STERIS by 4.9% during the 4th quarter. Ascent Group LLC now owns 1,009 shares of the medical equipment provider’s stock worth $256,000 after buying an additional 47 shares in the last quarter. Finally, Clear Harbor Asset Management LLC lifted its position in STERIS by 3.8% during the 4th quarter. Clear Harbor Asset Management LLC now owns 1,350 shares of the medical equipment provider’s stock worth $342,000 after buying an additional 50 shares in the last quarter. 94.69% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on the stock. KeyCorp lowered their price objective on shares of STERIS from $291.00 to $269.00 and set an “overweight” rating for the company in a research report on Wednesday, May 13th. Weiss Ratings cut shares of STERIS from a “hold (c+)” rating to a “hold (c)” rating in a research note on Wednesday, May 27th. Wall Street Zen cut shares of STERIS from a “strong-buy” rating to a “buy” rating in a research note on Saturday, June 6th. Finally, Piper Sandler reissued an “overweight” rating and issued a $270.00 price target on shares of STERIS in a report on Thursday, May 21st. Three equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $278.00.

STERIS Trading Up 1.7%

STE opened at $214.16 on Friday. The company has a debt-to-equity ratio of 0.25, a current ratio of 2.09 and a quick ratio of 1.54. The company has a market cap of $20.87 billion, a price-to-earnings ratio of 27.01 and a beta of 0.92. The firm has a 50 day simple moving average of $211.69 and a 200 day simple moving average of $227.60. STERIS plc has a fifty-two week low of $195.14 and a fifty-two week high of $269.44.

STERIS (NYSE:STE) last announced its quarterly earnings data on Monday, May 11th. The medical equipment provider reported $2.83 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.86 by ($0.03). STERIS had a net margin of 13.18% and a return on equity of 14.15%. The business had revenue of $1.59 billion during the quarter, compared to the consensus estimate of $1.59 billion. During the same period in the previous year, the business posted $2.74 earnings per share. STERIS’s revenue was up 6.7% compared to the same quarter last year. STERIS has set its FY 2027 guidance at 11.100-11.300 EPS. On average, sell-side analysts anticipate that STERIS plc will post 11.18 earnings per share for the current year.

STERIS Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, June 26th. Stockholders of record on Monday, June 8th were given a $0.63 dividend. This represents a $2.52 annualized dividend and a dividend yield of 1.2%. The ex-dividend date was Monday, June 8th. STERIS’s dividend payout ratio (DPR) is currently 31.78%.

Insider Transactions at STERIS

In related news, CEO Daniel A. Carestio sold 3,054 shares of STERIS stock in a transaction on Thursday, June 4th. The stock was sold at an average price of $214.64, for a total transaction of $655,510.56. Following the completion of the sale, the chief executive officer directly owned 65,021 shares of the company’s stock, valued at $13,956,107.44. The trade was a 4.49% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Richard C. Breeden sold 1,481 shares of the company’s stock in a transaction dated Tuesday, June 2nd. The shares were sold at an average price of $209.51, for a total value of $310,284.31. Following the completion of the sale, the director owned 38,964 shares of the company’s stock, valued at $8,163,347.64. This represents a 3.66% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 7,328 shares of company stock worth $1,554,051 in the last three months. Insiders own 1.12% of the company’s stock.

About STERIS

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.